Dr Prunella Blinman

Clinical Senior Lecturer
Medicine, Concord Clinical School

Telephone +61 2 9562 5089
Fax +61 2 9565 1863

Map

Current research students

Project title Research student
Pharmacokinetics based individualised dosing of anti cancer therapies for elderly patients Mohsen SHAFIEI

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Malalasekera, M., Dhillon, H., Blinman, P., Kao, S., Vardy, J. (2018). Delays to diagnosis and treatment of lung cancer in Australia: healthcare professional perceptions of actual versus acceptable timeframes. Internal Medicine Journal, 48(9), 1063-1071. [More Information]
  • Moth, E., Kiely, B., Naganathan, V., Martin, A., Blinman, P. (2018). How do oncologists make decisions about chemotherapy for their older patients with cancer? A survey of Australian oncologists. Supportive Care in Cancer, 26(2), 451-460. [More Information]
  • Karapetis, C., Stein, B., Koczwara, B., Harrup, R., Milleshkin, L., Parente, P., Millward, M., Haines, I., Blinman, P., Olver, I. (2018). Medical Oncology Group of Australia position statement and membership survey on voluntary assisted dying. Internal Medicine Journal, 48(7), 774-779. [More Information]
  • Blinman, P., Davis, I., Martin, A., Troon, S., Sengupta, S., Hovey, E., Coskinas, X., Kaplan, R., Ritchie, A., Meade, A., et al (2018). Patients' preferences for adjuvant sorafenib after resection of renal cell carcinoma in the SORCE trial: what makes it worthwhile? Annals of Oncology, 29(2), 370-376. [More Information]
  • Malalasekera, M., Blinman, P., Dhillon, H., Stefanic, N., Grimison, P., Jain, A., D'Souza, M., Kao, S., Vardy, J. (2018). Times to Diagnosis and Treatment of Lung Cancer in New South Wales, Australia: A Multicenter, Medicare Data Linkage Study. Journal of Oncology Practice, 14(10), e621-e630. [More Information]
  • Barnet, M., Blinman, P., Cooper, W., Boyer, M., Kao, S., Goodnow, C. (2018). Understanding Immune Tolerance of Cancer: Re-Purposing Insights from Fetal Allografts and Microbes. BioEssays, 40(8), 1-6. [More Information]
  • Dhillon, H., Bell, M., van der Ploeg, H., Turner, J., Kabourakis, M., Spencer, L., Lewis, C., Hui, R., Blinman, P., Clarke, S., Boyer, M., Vardy, J. (2017). Impact of physical activity on fatigue and quality of life in people with advanced lung cancer: A randomized controlled trial. Annals of Oncology, 28(8), 1889-1897. [More Information]
  • Ip, E., Pokorny, A., Della-Fiorentina, S., Beale, P., Bray, V., Kiely, B., Blinman, P. (2017). Use of palliative chemotherapy in patients aged 80 years and over with incurable cancer: experience at three Sydney cancer centres. Internal Medicine Journal, 47(1), 75-81. [More Information]
  • Moth, E., Vardy, J., Blinman, P. (2016). Decision-making in geriatric oncology: systemic treatment considerations for older adults with colon cancer. Expert Review of Gastroenterology and Hepatology, 10(12), 1321-1340. [More Information]
  • Blinman, P., Mileshkin, L., Khaw, P., Goss, G., Johnson, C., Capp, A., Brooks, S., Wain, G., Kolodziej, I., Veillard, A., O'Connell, R., Stockler, M., et al (2016). Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: An ANZGOG substudy of the PORTEC-3 intergroup randomised trial. British Journal of Cancer, 115(10), 1179-1185. [More Information]
  • Moth, E., McLachlan, S., Veillard, A., Muljadi, N., Hudson, M., Stockler, M., Blinman, P. (2016). Patients' preferred and perceived roles in making decisions about adjuvant chemotherapy for non-small-cell lung cancer. Lung Cancer, 95, 8-14. [More Information]
  • Moth, E., Parry, J., Stockler, M., Beale, P., Blinman, P., Della Fiorentina, S., Kiely, B. (2015). Doctor to doctor communication of prognosis in metastatic cancer: a review of letters from medical oncologists to referring doctors. Internal Medicine Journal, 45(9), 909-915. [More Information]
  • McCaughan, G., Blinman, P., Boyer, M., Stockler, M. (2013). Better estimates of survival for patients considering adjuvant chemotherapy after surgery for early non-small-cell lung cancer. Internal Medicine Journal, 43(4), 424-429. [More Information]
  • Kiely, B., Alam, M., Blinman, P., Tattersall, M., Stockler, M. (2012). Estimating typical, best-case and worst-case life expectancy scenarios for patients starting chemotherapy for advanced non-small-cell lung cancer: A systematic review of contemporary randomized trials. Lung Cancer, 77(3), 537-544. [More Information]
  • Blinman, P., King, M., Norman, R., Viney, R., Stockler, M. (2012). Preferences for cancer treatments: An overview of methods and applications in oncology. Annals of Oncology, 23(5), 1104-1110. [More Information]
  • Koczwara, B., Barton, M., Walpole, E., Grimison, P., Blinman, P., Crossing, S., Francis, K. (2012). Workforce shortages in medical oncology: a looming threat to quality cancer care. Medical Journal of Australia, 196(1), 32-33. [More Information]
  • Blinman, P., McLachlan, S., Nowak, A., Duric, V., Brown, C., Wright, G., Millward, M., Fong, K., Stockler, M. (2011). Lung cancer clinicians' preferences for adjuvant chemotherapy in non-small-cell lung cancer: What makes it worthwhile? Lung Cancer, 72(2), 213-218. [More Information]
  • Blinman, P., Duric, V., Nowak, A., Beale, P., Clarke, S., Briscoe, K., Boyce, A., Goldstein, D., Hudson, M., Stockler, M. (2010). Adjuvant chemotherapy for early colon cancer: What survival benefits make it worthwhile? European Journal of Cancer, 46(10), 1800-1807. [More Information]
  • Blinman, P., Alam, M., Duric, V., McLachlan, S., Stockler, M. (2010). Patients' preferences for chemotherapy in non-small-cell lung cancer: A systematic review. Lung Cancer, 69(2), 141-147. [More Information]
  • Blinman, P., Tattersall, M. (2009). A case of uterine tumour resembling ovarian sex cord tumour responding to second-line, single agent anastrazole. Internal Medicine Journal, 39(9), 617-619. [More Information]

2018

  • Malalasekera, M., Dhillon, H., Blinman, P., Kao, S., Vardy, J. (2018). Delays to diagnosis and treatment of lung cancer in Australia: healthcare professional perceptions of actual versus acceptable timeframes. Internal Medicine Journal, 48(9), 1063-1071. [More Information]
  • Moth, E., Kiely, B., Naganathan, V., Martin, A., Blinman, P. (2018). How do oncologists make decisions about chemotherapy for their older patients with cancer? A survey of Australian oncologists. Supportive Care in Cancer, 26(2), 451-460. [More Information]
  • Karapetis, C., Stein, B., Koczwara, B., Harrup, R., Milleshkin, L., Parente, P., Millward, M., Haines, I., Blinman, P., Olver, I. (2018). Medical Oncology Group of Australia position statement and membership survey on voluntary assisted dying. Internal Medicine Journal, 48(7), 774-779. [More Information]
  • Blinman, P., Davis, I., Martin, A., Troon, S., Sengupta, S., Hovey, E., Coskinas, X., Kaplan, R., Ritchie, A., Meade, A., et al (2018). Patients' preferences for adjuvant sorafenib after resection of renal cell carcinoma in the SORCE trial: what makes it worthwhile? Annals of Oncology, 29(2), 370-376. [More Information]
  • Malalasekera, M., Blinman, P., Dhillon, H., Stefanic, N., Grimison, P., Jain, A., D'Souza, M., Kao, S., Vardy, J. (2018). Times to Diagnosis and Treatment of Lung Cancer in New South Wales, Australia: A Multicenter, Medicare Data Linkage Study. Journal of Oncology Practice, 14(10), e621-e630. [More Information]
  • Barnet, M., Blinman, P., Cooper, W., Boyer, M., Kao, S., Goodnow, C. (2018). Understanding Immune Tolerance of Cancer: Re-Purposing Insights from Fetal Allografts and Microbes. BioEssays, 40(8), 1-6. [More Information]

2017

  • Dhillon, H., Bell, M., van der Ploeg, H., Turner, J., Kabourakis, M., Spencer, L., Lewis, C., Hui, R., Blinman, P., Clarke, S., Boyer, M., Vardy, J. (2017). Impact of physical activity on fatigue and quality of life in people with advanced lung cancer: A randomized controlled trial. Annals of Oncology, 28(8), 1889-1897. [More Information]
  • Ip, E., Pokorny, A., Della-Fiorentina, S., Beale, P., Bray, V., Kiely, B., Blinman, P. (2017). Use of palliative chemotherapy in patients aged 80 years and over with incurable cancer: experience at three Sydney cancer centres. Internal Medicine Journal, 47(1), 75-81. [More Information]

2016

  • Moth, E., Vardy, J., Blinman, P. (2016). Decision-making in geriatric oncology: systemic treatment considerations for older adults with colon cancer. Expert Review of Gastroenterology and Hepatology, 10(12), 1321-1340. [More Information]
  • Blinman, P., Mileshkin, L., Khaw, P., Goss, G., Johnson, C., Capp, A., Brooks, S., Wain, G., Kolodziej, I., Veillard, A., O'Connell, R., Stockler, M., et al (2016). Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: An ANZGOG substudy of the PORTEC-3 intergroup randomised trial. British Journal of Cancer, 115(10), 1179-1185. [More Information]
  • Moth, E., McLachlan, S., Veillard, A., Muljadi, N., Hudson, M., Stockler, M., Blinman, P. (2016). Patients' preferred and perceived roles in making decisions about adjuvant chemotherapy for non-small-cell lung cancer. Lung Cancer, 95, 8-14. [More Information]

2015

  • Moth, E., Parry, J., Stockler, M., Beale, P., Blinman, P., Della Fiorentina, S., Kiely, B. (2015). Doctor to doctor communication of prognosis in metastatic cancer: a review of letters from medical oncologists to referring doctors. Internal Medicine Journal, 45(9), 909-915. [More Information]

2013

  • McCaughan, G., Blinman, P., Boyer, M., Stockler, M. (2013). Better estimates of survival for patients considering adjuvant chemotherapy after surgery for early non-small-cell lung cancer. Internal Medicine Journal, 43(4), 424-429. [More Information]

2012

  • Kiely, B., Alam, M., Blinman, P., Tattersall, M., Stockler, M. (2012). Estimating typical, best-case and worst-case life expectancy scenarios for patients starting chemotherapy for advanced non-small-cell lung cancer: A systematic review of contemporary randomized trials. Lung Cancer, 77(3), 537-544. [More Information]
  • Blinman, P., King, M., Norman, R., Viney, R., Stockler, M. (2012). Preferences for cancer treatments: An overview of methods and applications in oncology. Annals of Oncology, 23(5), 1104-1110. [More Information]
  • Koczwara, B., Barton, M., Walpole, E., Grimison, P., Blinman, P., Crossing, S., Francis, K. (2012). Workforce shortages in medical oncology: a looming threat to quality cancer care. Medical Journal of Australia, 196(1), 32-33. [More Information]

2011

  • Blinman, P., McLachlan, S., Nowak, A., Duric, V., Brown, C., Wright, G., Millward, M., Fong, K., Stockler, M. (2011). Lung cancer clinicians' preferences for adjuvant chemotherapy in non-small-cell lung cancer: What makes it worthwhile? Lung Cancer, 72(2), 213-218. [More Information]

2010

  • Blinman, P., Duric, V., Nowak, A., Beale, P., Clarke, S., Briscoe, K., Boyce, A., Goldstein, D., Hudson, M., Stockler, M. (2010). Adjuvant chemotherapy for early colon cancer: What survival benefits make it worthwhile? European Journal of Cancer, 46(10), 1800-1807. [More Information]
  • Blinman, P., Alam, M., Duric, V., McLachlan, S., Stockler, M. (2010). Patients' preferences for chemotherapy in non-small-cell lung cancer: A systematic review. Lung Cancer, 69(2), 141-147. [More Information]

2009

  • Blinman, P., Tattersall, M. (2009). A case of uterine tumour resembling ovarian sex cord tumour responding to second-line, single agent anastrazole. Internal Medicine Journal, 39(9), 617-619. [More Information]

To update your profile click here. For support on your academic profile contact .